Estrogen Receptor in Knock out (ERIK) Cells

Abstract (Set) Receptor positive non-tumorigenic human breast epithelial cell line derived from the commercially available MCF-10A human breast epithelial cell line with the p21 gene somatically deleted. Description (Set) Proposed Use (Set) The cell lines described in this invention can be used in screens for novel molecules target ER+ positive breast cancer or to confirm the specificity of drugs discovered through other approaches. Such drugs can potentially be used as chemotherapeutic or chemopreventive agents

Inventor(s): Park, Ben Ho

Type of Offer: Licensing

Next Patent »
« More Medical Patents

Share on      

CrowdSell Your Patent